Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated May 17, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Springworks Therapeutics, Inc.
| 4.09K |
—
|
—
| +27.85% | 18.8K |
May 16
| |||||||
Solventum Corp
|
0
|
—
|
—
|
—
|
0
|
May 13
| |||||||
Solventum Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Springworks Therapeutics, Inc.
| 4.65K |
—
|
—
| +46.21% | 14.71K |
May 24
| |||||||
Springworks Therapeutics, Inc.
| 10.06K |
—
|
—
|
∞
| 10.06K |
Jul 14
| |||||||
Springworks Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Abbvie Inc.
|
0
|
$67.94 | -$7,427,019.60 |
—
| 114.9K |
Nov 16
| |||||||
Abbvie Inc.
| -53.33K |
$100.00 | -$5,332,554.58 | -31.70% | 114.9K |
Jul 7
| |||||||
Abbvie Inc.
| -32.09K |
$85.42 | -$2,741,298.64 | -16.02% | 168.22K |
Feb 28
| |||||||
Abbvie Inc.
| 72.44K |
—
|
—
| +56.65% | 200.32K |
Feb 20
| |||||||
Abbvie Inc.
| -24.13K |
$79.41 | -$1,915,766.25 | -15.87% | 127.88K |
Feb 28
| |||||||
Abbvie Inc.
| 54.45K |
—
|
—
| +55.82% | 152K |
Feb 21
| |||||||
Abbvie Inc.
| -61.45K |
$72.31 | -$11,234,863.73 | -38.65% | 97.55K | +1 |
Feb 28 - Mar 1
| ||||||
Abbvie Inc.
| 44.26K |
—
|
—
| +18.16% | 287.95K | +1 |
Feb 15
| ||||||
Abbvie Inc.
|
0
|
$47.11 | -$2,097,264.44 |
—
| 114.75K | +1 |
Jun 14
| ||||||
Abbvie Inc.
| -43.00K |
$67.00 | -$2,881,000.00 | -27.26% | 114.75K | +1 |
May 4
| ||||||
Abbvie Inc.
| -34.72K |
$62.22 | -$2,160,340.62 | -18.04% | 157.75K | +1 |
Feb 28
| ||||||
Abbvie Inc.
| 43.02K |
—
|
—
| +28.79% | 192.47K | +1 |
Feb 16
| ||||||
Abbvie Inc.
| -47.44K |
$63.52 | -$3,013,261.76 | -24.09% | 149.44K | +1 |
May 10
| ||||||
Abbvie Inc.
| -39.93K |
$56.00 | -$2,236,080.00 | -16.86% | 196.88K | +1 |
Feb 29
| ||||||
Abbvie Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Feb 18
| ||||||
Abbvie Inc.
| -19.91K |
$60.51 | -$1,204,567.12 | -7.75% | 236.81K | +1 |
Feb 27 - Feb 28
| ||||||
Abbvie Inc.
| 51.58K |
—
|
—
| +25.14% | 256.72K | +1 |
Feb 19
| ||||||
Abbvie Inc.
| -18.20K |
$50.78 | -$924,246.07 | -8.15% | 205.14K | +1 |
Feb 28 - Mar 3
| ||||||
Abbvie Inc.
| 47.26K |
—
|
—
| +26.84% | 223.34K | +1 |
Feb 20
| ||||||
Abbvie Inc.
| 29.24K |
$36.82 | -$1,197,336.50 | +19.92% | 176.08K | +1 |
May 1
| ||||||
Abbvie Inc.
| -12.96K |
$36.73 | -$476,020.80 | -8.11% | 146.84K | +1 |
Feb 28
| ||||||
Abbvie Inc.
| 46.87K |
$37.58 | -$369,261.08 | +41.51% | 159.79K | +1 |
Feb 14 - Feb 19
| ||||||
Abbvie Inc.
| 157 |
$35.54 | -$2,789.36 | +0.14% | 112.92K | +1 |
Feb 5
| ||||||
Abbvie Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Abbott Laboratories
| 18.45K |
—
|
—
| +15.68% | 136.14K |
Nov 16 - Dec 1
| |||||||
Abbott Laboratories
| 2.87K |
$69.28 | -$140,776.96 | +2.50% | 117.69K |
Oct 15
| |||||||
Abbott Laboratories
|
0
|
$63.63 | -$15,274.50 |
—
| 114.82K |
Sep 25
| |||||||
Abbott Laboratories
|
0
|
$63.36 | -$24,492.86 |
—
| 114.82K |
Sep 20
| |||||||
Abbott Laboratories
|
0
|
$62.38 | -$16,970.25 |
—
| 114.82K |
Sep 13
| |||||||
Abbott Laboratories
| -352.00 |
$66.62 | -$23,451.30 | -0.31% | 114.82K |
Jul 30
| |||||||
Abbott Laboratories
|
0
|
$54.07 | -$982,856.10 |
—
| 115.17K |
Jul 27
| |||||||
Abbott Laboratories
| 1.1K |
$56.99 | -$16,112.18 | +0.97% | 115.17K |
Jul 23
| |||||||
Abbott Laboratories
| -824.00 |
$60.22 | -$49,622.18 | -100.00% |
0
|
Mar 20
| |||||||
Abbott Laboratories
| -5.91K |
$57.00 | -$574,113.17 | -4.92% | 114.07K |
Feb 29
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.